Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nudix hydrolase 4 (NUDT4) is an enzyme that catalyzes the hydrolysis of the beta-phosphate from diphosphoinositol polyphosphates, such as diphosphoinositol pentakisphosphate (PP-InsP5) and diphosphoinositol tetrakisphosphate (PP-InsP4), which are high-energy signaling molecules involved in regulation of intracellular signaling and trafficking[1][5][6]. NUDT4 also acts on diadenosine polyphosphates (notably Ap6A and Ap5A) and can hydrolyze 5-phosphoribose 1-diphosphate, a glycolytic activator[1][5][6]. It is involved in pathways related to metabolic regulation, with proposed but not firmly established roles in cellular signaling cascades, and does not show major known disease associations or therapeutic interactions at present[1][3][6]. Multiple alternatively spliced isoforms exist, such as DIPP2alpha and DIPP2beta, but the main biochemical activity is hydrolysis of diphosphoinositol polyphosphates[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nudix hydrolase 4 (NUDT4).